Welch & Forbes LLC trimmed its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,491 shares of the semiconductor company’s stock after selling 2,065 shares during the period. Welch & Forbes LLC’s holdings in Synopsys were worth $13,278,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also made changes to their positions in the stock. China Universal Asset Management Co. Ltd. grew its stake in Synopsys by 31.8% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock worth $6,957,000 after buying an additional 3,575 shares in the last quarter. SeaTown Holdings Pte. Ltd. lifted its holdings in shares of Synopsys by 55.9% during the 4th quarter. SeaTown Holdings Pte. Ltd. now owns 22,300 shares of the semiconductor company’s stock worth $10,475,000 after acquiring an additional 8,000 shares during the period. Norges Bank acquired a new stake in shares of Synopsys during the 4th quarter worth approximately $730,197,000. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Synopsys by 11.3% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 131,369 shares of the semiconductor company’s stock worth $61,707,000 after acquiring an additional 13,320 shares in the last quarter. Finally, Douglas Lane & Associates LLC increased its stake in Synopsys by 5,701.2% in the fourth quarter. Douglas Lane & Associates LLC now owns 48,730 shares of the semiconductor company’s stock valued at $22,889,000 after acquiring an additional 47,890 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.
Synopsys Trading Up 0.5%
Shares of NASDAQ:SNPS traded up $2.13 during mid-day trading on Friday, reaching $445.50. 839,512 shares of the company’s stock were exchanged, compared to its average volume of 1,858,163. The firm has a market capitalization of $85.30 billion, a price-to-earnings ratio of 103.12, a PEG ratio of 2.62 and a beta of 1.22. The business’s fifty day moving average price is $477.80 and its 200-day moving average price is $460.71. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73.
Insider Transactions at Synopsys
In other news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.56% of the company’s stock.
Analyst Upgrades and Downgrades
SNPS has been the subject of several recent analyst reports. Bank of America upped their target price on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Robert W. Baird set a $558.00 price target on Synopsys in a report on Thursday, May 28th. Stifel Nicolaus upped their price objective on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Needham & Company LLC reaffirmed a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Finally, Rosenblatt Securities lifted their target price on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $570.06.
Check Out Our Latest Stock Analysis on SNPS
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
